Xenon Pharmaceuticals Inc. ($XENE)
Filing Information
| Accession Number | 0001193125-26-102667 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 11, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
25,107
Total Value
$156,701.56
P&L
+inf% (+$419,100.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Shares | โ | Mar 9, 2026 | Exercise/Conversion | 7,500 | โ | โ | 7,500 | Direct | โ | View Details | |
Chief Legal Officer | Common Shares | โ | Mar 10, 2026 | Sale | 2,607 | $60.11 | $156,701.56 | 4,893 | Direct | โ | View Details | |
Chief Legal Officer | Performance Share Units | Derivative | Mar 9, 2026 | Grant/Award | 7,500 | $0.00 | $0.00 | 7,500 | Direct | โ | View Details | |
Chief Legal Officer | Performance Share Units | Derivative | Mar 9, 2026 | Exercise/Conversion | 7,500 | $0.00 | $0.00 | 0 | Direct | โ | View Details |